These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23826301)

  • 21. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.
    Wagner B; Goodman LB; Rollins A; Freer HS
    Equine Vet J; 2013 Sep; 45(5):533-7. PubMed ID: 23432019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.
    Jobe DA; Lovrich SD; Asp KE; Mathiason MA; Albrecht SE; Schell RF; Callister SM
    Clin Vaccine Immunol; 2008 Jun; 15(6):981-5. PubMed ID: 18417666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
    J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.
    Gilmore RD; Kappel KJ; Dolan MC; Burkot TR; Johnson BJ
    Infect Immun; 1996 Jun; 64(6):2234-9. PubMed ID: 8675332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive seroprofiling of sixteen B. burgdorferi OspC: implications for Lyme disease diagnostics design.
    Ivanova L; Christova I; Neves V; Aroso M; Meirelles L; Brisson D; Gomes-Solecki M
    Clin Immunol; 2009 Sep; 132(3):393-400. PubMed ID: 19576856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope mapping of Borrelia burgdorferi OspC protein in homodimeric fold.
    Norek A; Janda L
    Protein Sci; 2017 Apr; 26(4):796-806. PubMed ID: 28142214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi.
    Gilmore RD; Bacon RM; Carpio AM; Piesman J; Dolan MC; Mbow ML
    J Med Microbiol; 2003 Jul; 52(Pt 7):551-556. PubMed ID: 12808075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease.
    Lovrich SD; La Fleur RL; Jobe DA; Johnson JC; Asp KE; Schell RF; Callister SM
    Clin Vaccine Immunol; 2007 May; 14(5):635-7. PubMed ID: 17344346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal disulfide-bridging of Borrelia outer surface protein C increases its diagnostic and vaccine potentials.
    Probst C; Ott A; Scheper T; Meyer W; Stöcker W; Komorowski L
    Ticks Tick Borne Dis; 2012 Feb; 3(1):1-7. PubMed ID: 22309852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease.
    Arnaboldi PM; Seedarnee R; Sambir M; Callister SM; Imparato JA; Dattwyler RJ
    Clin Vaccine Immunol; 2013 Apr; 20(4):474-81. PubMed ID: 23365204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif.
    Mathiesen MJ; Holm A; Christiansen M; Blom J; Hansen K; Ostergaard S; Theisen M
    Infect Immun; 1998 Sep; 66(9):4073-9. PubMed ID: 9712750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
    Oliver LD; Earnhart CG; Virginia-Rhodes D; Theisen M; Marconi RT
    Vet J; 2016 Dec; 218():27-33. PubMed ID: 27938705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection.
    Fung BP; McHugh GL; Leong JM; Steere AC
    Infect Immun; 1994 Aug; 62(8):3213-21. PubMed ID: 8039891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.
    Ikushima M; Matsui K; Yamada F; Kawahashi S; Nishikawa SK
    FEMS Immunol Med Microbiol; 2000 Sep; 29(1):15-21. PubMed ID: 10967255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
    LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
    Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.
    Rousselle JC; Callister SM; Schell RF; Lovrich SD; Jobe DA; Marks JA; Wieneke CA
    J Infect Dis; 1998 Sep; 178(3):733-41. PubMed ID: 9728542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
    Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.
    Rogovskyy AS; Gillis DC; Ionov Y; Gerasimov E; Zelikovsky A
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27799330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.
    Guarino C; Asbie S; Rohde J; Glaser A; Wagner B
    Vaccine; 2017 Jul; 35(33):4140-4147. PubMed ID: 28668566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.